Giving meaning to breast cancer

Researchers from the Saw Swee Hock School of Public Health (SSHSPH) and NUS Medicine, as well as area studies specialists, anthropologists and the medical community have completed their first pilot study investigating the non-medical and cultural complexities that may influence breast cancer literacy in Asia.

Read More

Addressing healthcare challenges

Researchers from NUS and the National University Health System (NUHS) are part of two teams awarded $5.1 million in funding for up to three years through the Johnson & Johnson World Without Disease Grant Call Collaboration with Singapore’s Agency for Science, Technology and Research (A*STAR).

Read More

Taking action against dementia

As dementia becomes increasingly common in Singapore, Associate Professor Reshma Merchant shares her insights on risk factors that may contribute to dementia, such as hearing loss, and how community efforts such as the Healthy Ageing Programme For You (HAPPY) can potentially delay the onset of dementia for Singaporeans.

Read More

Myeloma patients boosted by new approved drug

The approved usage of a new drug called carfilzomib by the Health Sciences Authority will give a boost to myeloma patients, as it may increase the amount of time they spend without their condition worsening, according to the National University Cancer Institute, Singapore (NCIS).

Read More

Cadavers and anatomy classes - the past and present

Dr Chong Siow Ann, an alumnus of NUS Medicine, reflects on his experience with cadavers in anatomy classes and highlights the importance of cadavers in nurturing future doctors, as an increase in body donations has allowed NUS Yong Loo Lin School of Medicine to resume dissection of cadavers.

Read More

Hearing loss linked to dementia

A study on Singaporeans using results from the Singapore Longitudinal Ageing Study has revealed that people aged 55 and above with hearing loss are more likely to develop dementia.

Read More

Scientists grow liver cancer cells in lab

An interdisciplinary team of NUS researchers have discovered a way to grow patient-derived xenografts of liver cancer cells using synthetic 3D scaffolds made of a plant-based porous hydrogel. The new discovery could pave the way for more cost and time efficient methods to test for drug efficacy in the future.

Read More